RVL Pharmaceuticals plc (NASDAQ: RVLP) Q4 2022 earnings call dated Mar. 20, 2023 Corporate Participants: Lisa Wilson -- Investor Relations Brian Markison -- Chief Executive Officer
RVL Pharmaceuticals PLC
-(RVLP)
XNAS:RVLP
News . Data . Research